Cellectar Biosciences Return on Net Operating Assets Insights

Cellectar Biosciences, Inc. (CLRB)

3.20 -0.03 (-0.93%) USD | NASDAQ | Mar 13, 16:00

3.27 +0.07 (+2.19%) After-Hours: 20:00

View Return on Net Operating Assets for CLRB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

EyePoint Plc	Upgrade
Ocugen, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	Upgrade